Dr. Lori Schleicher

Claim this profile

Newark Beth Israel Medical Center

Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
4 reported clinical trials
10 drugs studied

Area of expertise

1Non-Small Cell Lung Cancer
Lori Schleicher has run 2 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage II
Stage I
Stage III
2Lung Cancer
Lori Schleicher has run 2 trials for Lung Cancer. Some of their research focus areas include:
Stage II
Stage I
Stage III

Affiliated Hospitals

Image of trial facility.
Newark Beth Israel Medical Center

Clinical Trials Lori Schleicher is currently running

Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria

More about Lori Schleicher

Clinical Trial Related7 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Lori Schleicher has experience with
  • Biospecimen Collection
  • Crizotinib
  • Cetuximab
  • Irinotecan Hydrochloride
  • Pertuzumab
  • Trastuzumab
Breakdown of trials Lori Schleicher has run
Non-Small Cell Lung Cancer
Lung Cancer
Thyroid Cancer
Anaplastic Large Cell Lymphoma
ALK Gene Rearrangement

Other Doctors you might be interested in

Shridar GanesanRutgers Cancer Institute of New Jersey
Lara HathoutRutgers Cancer Institute of New Jersey
Howard S. HochsterRutgers Cancer Institute of New Jersey

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lori Schleicher specialize in?
Lori Schleicher focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage II patients, or patients who are Stage I.
Is Lori Schleicher currently recruiting for clinical trials?
Yes, Lori Schleicher is currently recruiting for 1 clinical trial in Newark New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Lori Schleicher has studied deeply?
Yes, Lori Schleicher has studied treatments such as Biospecimen Collection, Crizotinib, Cetuximab.
What is the best way to schedule an appointment with Lori Schleicher?
Apply for one of the trials that Lori Schleicher is conducting.
What is the office address of Lori Schleicher?
The office of Lori Schleicher is located at: Newark Beth Israel Medical Center, Newark, New Jersey 07112 United States. This is the address for their practice at the Newark Beth Israel Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security